Patient Demographics > Country of Treatment > Poland

You are looking at 1 - 6 of 6 items

Ewa Stogowska Department of Internal Medicine and Metabolic Diseases, Medical University of Białystok, Bialystok, Poland

Search for other papers by Ewa Stogowska in
Google Scholar
PubMed
Close
,
Agnieszka Łebkowska Department of Internal Medicine and Metabolic Diseases, Medical University of Białystok, Bialystok, Poland

Search for other papers by Agnieszka Łebkowska in
Google Scholar
PubMed
Close
,
Maria Kościuszko Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Białystok, Bialystok, Poland

Search for other papers by Maria Kościuszko in
Google Scholar
PubMed
Close
,
Grzegorz Zieliński Department of Neurosurgery, Military Institute of Medicine, Warsaw, Poland

Search for other papers by Grzegorz Zieliński in
Google Scholar
PubMed
Close
,
Irina Kowalska Department of Internal Medicine and Metabolic Diseases, Medical University of Białystok, Bialystok, Poland

Search for other papers by Irina Kowalska in
Google Scholar
PubMed
Close
, and
Monika Karczewska-Kupczewska Department of Internal Medicine and Metabolic Diseases, Medical University of Białystok, Bialystok, Poland

Search for other papers by Monika Karczewska-Kupczewska in
Google Scholar
PubMed
Close

Summary

We report a case of a 59-year-old woman with Cushing’s disease who developed hyperthyroidism following treatment of hypercortisolaemia. The patient with a history of recurrent hospitalisations caused by multi-sited soft tissue abscesses was admitted with sepsis. Both her medical history and physical examination suggested Cushing’s syndrome. The initial hormonal diagnostic process, conducted after sepsis treatment, brought forth conflicting results. However, hormonal assessment repeated 3 months later indicated pituitary hypercortisolaemia, which was confirmed through bilateral inferior petrosal sinus sampling and was successfully treated with transsphenoidal pituitary surgery. Three months after the surgery, the patient was readmitted to our epartment with symptoms of hyperthyroidism, which was confirmed by laboratory tests. Thyroid scintiscans indicated Graves’ disease. However, the absence of anti-thyroid stimulating hormone antibodies suggested other etiologies of hyperthyroidism. Eventually, the patient underwent radioiodine therapy. Currently, her condition is improving and she has had no recurrence of abscesses, severe infections, or hyperthyroidism. In conclusion, while clinical manifestation of hypercortisolaemia might be non-specific, its treatment may trigger the development of autoimmune diseases.

Learning points

  • The presence of recurrent severe infections should prompt physicians to consider the possibility of hypercortisolaemia.

  • Chronic hypercortisolism is debilitating and can lead to significant disability.

  • Dexamethasone suppression testing in patients with active or recent severe inflammatory or infectious illnesses may produce misleading or confusing results.

  • Clinicians should be aware of the potential development of autoimmune diseases following successful treatment of hypercortisolaemia.

Open access
Joanna Chrzanowska Department of Pediatrics, Endocrinology, Diabetology and Metabolic Diseases for Children and Adolescents, Wrocław Medical University, Poland

Search for other papers by Joanna Chrzanowska in
Google Scholar
PubMed
Close
,
Monika Seifert Department of Pediatrics, Endocrinology, Diabetology and Metabolic Diseases for Children and Adolescents, Wrocław Medical University, Poland

Search for other papers by Monika Seifert in
Google Scholar
PubMed
Close
,
Barbara Salmonowicz Department of Pediatrics, Endocrinology, Diabetology and Metabolic Diseases for Children and Adolescents, Wrocław Medical University, Poland

Search for other papers by Barbara Salmonowicz in
Google Scholar
PubMed
Close
, and
Agnieszka Zubkiewicz-Kucharska Department of Pediatrics, Endocrinology, Diabetology and Metabolic Diseases for Children and Adolescents, Wrocław Medical University, Poland

Search for other papers by Agnieszka Zubkiewicz-Kucharska in
Google Scholar
PubMed
Close

Summary

The etiology of foot drop is diverse from various diseases to mechanic injuries and includes neuropathy of the peroneal nerve. Peroneal neuropathy might also be one of the forms of diabetic neuropathy, very rarely reported as the first sign of diabetes. We describe three cases of children with newly diagnosed type 1 diabetes (TID) who developed unilateral peroneal nerve palsies and tibial nerve palsies, presenting clinically as a foot drop. In two of our cases, the symptoms of foot drop occurred shortly after starting treatment for severe diabetes ketoacidosis. In the third patient, food drop was a reason for the initial medical consultation, but eventually, TID was diagnosed. The presented cases highlight that neuropathy can be observed not only as a chronic complication of T1D, but it can also appear at the time of disease manifestation. The incorrect position of the lower limb during a keto coma may contribute to the development of neuropathy.

Learning points

  • Neuropathy can be observed not only as a chronic complication of type 1 diabetes (T1D), but it can also appear at the time of disease manifestation.

  • The incorrect position of the lower limb causing external pressure during a keto coma may contribute to the development of neuropathy.

  • It is important to examine the glycemia in patients with acute peroneal neuropathy, as this kind of peripheral neuropathy can be associated with newly diagnosed T1D. Normalization of glycemia might lead to rapid neuronal recovery.

Open access
Katarzyna Guziejko 2nd Department of Lung Diseases and Tuberculosis

Search for other papers by Katarzyna Guziejko in
Google Scholar
PubMed
Close
,
Łukasz Minarowski 2nd Department of Lung Diseases and Tuberculosis

Search for other papers by Łukasz Minarowski in
Google Scholar
PubMed
Close
,
Agata Piłaszewicz-Puza Department of Medical Pathomorphology, Medical University of Bialystok, Bialystok, Poland

Search for other papers by Agata Piłaszewicz-Puza in
Google Scholar
PubMed
Close
,
Anna Szumera-Ciećkiewicz Department of Pathology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

Search for other papers by Anna Szumera-Ciećkiewicz in
Google Scholar
PubMed
Close
, and
Robert Marek Mróz 2nd Department of Lung Diseases and Tuberculosis

Search for other papers by Robert Marek Mróz in
Google Scholar
PubMed
Close

Summary

Sarcoidosis is an inflammatory, multisystem disease with an undetermined etiology. The presence of noncaseating granulomas in involved organs is a characteristic pathomorphological feature. Sarcoidosis, like a chameleon, can mimic different medical conditions. Although the lungs are most commonly involved, extrapulmonary manifestations can influence any system. The clinical course of the disease may differ. Immediate initiation of glucocorticosteroid therapy is important when critical organs are impaired. A case of a patient with sarcoidosis whose first clinical symptoms were related to diabetes insipidus (DI) was presented. The diagnosis of multiple organ sarcoidosis was delayed because of an adequate response to treatment with vasopressin. The multidisciplinary diagnostic approach validated the involvement of the pituitary gland, lungs, lymph nodes, bones, and subcutaneous tissue. The presented case emphasizes the critical importance of the multifaceted differential diagnosis of patients with DI.

Learning points

  • Sarcoidosis usually affects the lung but can also be a multisystemic disease.

  • The assessment of the extension of sarcoidosis remains complex.

  • A multidisciplinary approach must identify all-organ involvement and initiate appropriate sarcoidosis treatment.

  • Diabetes insipidus (DI) can be the first symptom of a systemic granulomatous disorder.

  • In the differential diagnosis of DI, a comprehensive assessment of rare causes of endocrine disorders, including extrapulmonary sarcoidosis, should be considered.

Open access
Alicja Szwilling Department of Pediatric Diabetology and Pediatrics, Children Teaching Clinical Hospital

Search for other papers by Alicja Szwilling in
Google Scholar
PubMed
Close
,
Katarzyna Dzygalo Department of Pediatric Diabetology and Pediatrics, Children Teaching Clinical Hospital

Search for other papers by Katarzyna Dzygalo in
Google Scholar
PubMed
Close
, and
Jędrzej Nowaczyk Department of Pediatrics, Medical University of Warsaw, Warszawa, Poland

Search for other papers by Jędrzej Nowaczyk in
Google Scholar
PubMed
Close

Summary

Kearns–Sayre syndrome (KSS) is a multi-system mitochondrial disease with wide clinical presentation. We describe the case of a 16-year-old girl with KSS accompanied by insulin-dependent diabetes, eosinophilic esophagitis (EoE), Fanconi syndrome, insufficiency of parathyroid gland and severe nutritional problems. Based on recent knowledge, ketogenic diet was introduced to improve metabolic and neurological condition, however in our patient we observed its bad consequences. Unresolved nutritional disorders forced us to proceed with esophagogastroduodenoscopy which revealed EoE. PEG procedure was performed and elemental diet with PPI’s was introduced leading to general improvement in the patient’s health condition.

Learning points:

  • Nutrition is an important factor in supportive care of patients with KSS.

  • Ketogenic diet in patients affected by mitochondrial diseases and diabetes requires careful selection and monitoring.

  • To the best of our knowledge, this is the first case that shows the coexistence of EoE, insulin-dependent diabetes and KSS.

Open access
Agnieszka Łebkowska Department of Internal Medicine and Metabolic Diseases, Diabetology and Internal Medicine

Search for other papers by Agnieszka Łebkowska in
Google Scholar
PubMed
Close
,
Anna Krentowska Department of Internal Medicine and Metabolic Diseases, Diabetology and Internal Medicine

Search for other papers by Anna Krentowska in
Google Scholar
PubMed
Close
,
Agnieszka Adamska Department of Endocrinology, Diabetology and Internal Medicine

Search for other papers by Agnieszka Adamska in
Google Scholar
PubMed
Close
,
Danuta Lipińska Department of Endocrinology, Diabetology and Internal Medicine

Search for other papers by Danuta Lipińska in
Google Scholar
PubMed
Close
,
Beata Piasecka Department of Endocrinology, Diabetology and Internal Medicine

Search for other papers by Beata Piasecka in
Google Scholar
PubMed
Close
,
Otylia Kowal-Bielecka Department of Rheumatology and Internal Diseases, Medical University of Bialystok, Bialystok, Poland

Search for other papers by Otylia Kowal-Bielecka in
Google Scholar
PubMed
Close
,
Maria Górska Department of Endocrinology, Diabetology and Internal Medicine

Search for other papers by Maria Górska in
Google Scholar
PubMed
Close
,
Robert K Semple Centre for Cardiovascular Science, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK

Search for other papers by Robert K Semple in
Google Scholar
PubMed
Close
, and
Irina Kowalska Department of Internal Medicine and Metabolic Diseases, Diabetology and Internal Medicine

Search for other papers by Irina Kowalska in
Google Scholar
PubMed
Close

Summary

Type B insulin resistance syndrome (TBIR) is characterised by the rapid onset of severe insulin resistance due to circulating anti-insulin receptor antibodies (AIRAs). Widespread acanthosis nigricans is normally seen, and co-occurrence with other autoimmune diseases is common. We report a 27-year-old Caucasian man with psoriasis and connective tissue disease who presented with unexplained rapid weight loss, severe acanthosis nigricans, and hyperglycaemia punctuated by fasting hypoglycaemia. Severe insulin resistance was confirmed by hyperinsulinaemic euglycaemic clamping, and immunoprecipitation assay demonstrated AIRAs, confirming TBIR. Treatment with corticosteroids, metformin and hydroxychloroquine allowed withdrawal of insulin therapy, with stabilisation of glycaemia and diminished signs of insulin resistance; however, morning fasting hypoglycaemic episodes persisted. Over three years of follow-up, metabolic control remained satisfactory on a regimen of metformin, hydroxychloroquine and methotrexate; however, psoriatic arthritis developed. This case illustrates TBIR as a rare but severe form of acquired insulin resistance and describes an effective multidisciplinary approach to treatment.

Learning points:

  • We describe an unusual case of type B insulin resistance syndrome (TBIR) in association with mixed connective tissue disease and psoriasis.

  • Clinical evidence of severe insulin resistance was corroborated by euglycaemic hyperinsulinaemic clamp, and anti-insulin receptor autoantibodies were confirmed by immunoprecipitation assay.

  • Treatment with metformin, hydroxychloroquine and methotrexate ameliorated extreme insulin resistance.

Open access
Anna Popławska-Kita Departments of Endocrinology, Diabetology and Internal Medicine

Search for other papers by Anna Popławska-Kita in
Google Scholar
PubMed
Close
,
Marta Wielogórska Departments of Endocrinology, Diabetology and Internal Medicine

Search for other papers by Marta Wielogórska in
Google Scholar
PubMed
Close
,
Łukasz Poplawski Radiology, Medical University of Bialystok, Bialystok, Poland

Search for other papers by Łukasz Poplawski in
Google Scholar
PubMed
Close
,
Katarzyna Siewko Departments of Endocrinology, Diabetology and Internal Medicine

Search for other papers by Katarzyna Siewko in
Google Scholar
PubMed
Close
,
Agnieszka Adamska Departments of Endocrinology, Diabetology and Internal Medicine

Search for other papers by Agnieszka Adamska in
Google Scholar
PubMed
Close
,
Piotr Szumowski Departments of Nuclear Medicine, Medical University of Bialystok, Bialystok, Poland

Search for other papers by Piotr Szumowski in
Google Scholar
PubMed
Close
,
Piotr Myśliwiec 1st Clinic Department of General and Endocrine Surgery, Medical University of Bialystok, Bialystok, Poland

Search for other papers by Piotr Myśliwiec in
Google Scholar
PubMed
Close
,
Janusz Myśliwiec Departments of Nuclear Medicine, Medical University of Bialystok, Bialystok, Poland

Search for other papers by Janusz Myśliwiec in
Google Scholar
PubMed
Close
,
Joanna Reszeć Departments of Medical Pathomorphology, Medical University of Bialystok, Bialystok, Poland

Search for other papers by Joanna Reszeć in
Google Scholar
PubMed
Close
,
Grzegorz Kamiński Department of Endocrinology and Radioisotopy Therapy, Military Institute of Medicine, Warsaw, Poland

Search for other papers by Grzegorz Kamiński in
Google Scholar
PubMed
Close
,
Janusz Dzięcioł Departments of Human Anatomy, Medical University of Bialystok, Bialystok, Poland

Search for other papers by Janusz Dzięcioł in
Google Scholar
PubMed
Close
,
Dorota Tobiaszewska Departments of Endocrinology, Diabetology and Internal Medicine

Search for other papers by Dorota Tobiaszewska in
Google Scholar
PubMed
Close
,
Małgorzata Szelachowska Departments of Endocrinology, Diabetology and Internal Medicine

Search for other papers by Małgorzata Szelachowska in
Google Scholar
PubMed
Close
, and
Adam Jacek Krętowski Departments of Endocrinology, Diabetology and Internal Medicine

Search for other papers by Adam Jacek Krętowski in
Google Scholar
PubMed
Close

Summary

Papillary thyroid gland carcinoma is the most common type of malignancy of the endocrine system. Metastases to the pituitary gland have been described as a complication of papillary thyroid cancer in few reported cases since 1965. We report the case of a 68-year-old female patient with a well-differentiated form of thyroid gland cancer. Despite it being the most common malignant cancer of the endocrine system, with its papillary form being one of the two most frequently diagnosed thyroid cancers, the case we present is extremely rare. Sudden cardiac arrest during ventricular fibrillation occurred during hospitalization. Autopsy of the patient revealed papillary carcinoma of the thyroid, follicular variant, with metastasis to the sella turcica, and concomitant sarcoidosis of heart, lung, and mediastinal and hilar lymph nodes. Not only does atypical metastasis make our patient’s case most remarkable, but also the postmortem diagnosis of sarcoidosis makes her case particularly unusual.

Learning points:

  • The goal of presenting this case is to raise awareness of the clinical heterogeneity of papillary cancer and promote early diagnosis of unexpected metastasis and coexisting diseases to improve clinical outcomes.

  • Clinicians must be skeptical. They should not fall into the trap of diagnostic momentum or accept diagnostic labels at face value. Regardless of the potential mechanisms, clinicians should be aware of the possibility of the coexistence of thyroid cancer and sarcoidosis as a differential diagnosis of lymphadenopathy.

  • This case highlights the importance of the diagnostic and therapeutic planning process and raises awareness of the fact that one uncommon disease could be masked by another extremely rare disorder.

Open access